Number of items: 7.
2018
Ghesquières, H. et al.
(2018)
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts.
British Journal of Haematology, 180(2),
pp. 286-290.
(doi: 10.1111/bjh.14306)
(PMID:27716907)
(PMCID:PMC5344766)
2016
Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M.
(2016)
An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events.
Leukemia and Lymphoma, 57(11),
pp. 2568-2574.
(doi: 10.3109/10428194.2016.1165815)
(PMID:27078747)
2013
Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S.
(2013)
High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles.
Leukemia and Lymphoma, 54(10),
pp. 2303-2305.
(doi: 10.3109/10428194.2013.769536)
2012
Farrell, K. and Rule, S.
(2012)
Mantle-cell lymphoma in the elderly: is it time to CHOP and change?
Leukemia and Lymphoma, 53(10),
pp. 1855-1856.
(doi: 10.3109/10428194.2012.695361)
2011
Farrell, K., McKay, P. and Leach, M.
(2011)
Nodular lymphocyte predominant Hodgkin lymphoma behaves as a
distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network.
Leukemia and Lymphoma, 52(10),
pp. 1920-1928.
(doi: 10.3109/10428194.2011.584993)
Farrell, K., Stobo, D. and Soutar, R.
(2011)
Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone.
Journal of Clinical Oncology, 29(17),
e512-e513.
(doi: 10.1200/JCO.2011.34.6452)
Farrell, K. and Jarrett, R.F.
(2011)
The molecular pathogenesis of Hodgkin lymphoma.
Histopathology, 58(1),
pp. 15-25.
(doi: 10.1111/j.1365-2559.2010.03705.x)
This list was generated on Fri Dec 6 09:48:04 2024 GMT.